{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:28Z","timestamp":1791839968941,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd004349","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000}}],"reference-count":76,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004349.pub2","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T10:56:41Z","timestamp":1246618601000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Treatment blood pressure targets for hypertension"],"prefix":"10.1002","author":[{"given":"Jose Agustin","family":"Arguedas","sequence":"first","affiliation":[{"name":"Universidad de Costa Rica; Depto de Farmacologia Clinica, Facultad de Medicina; San Pedro de Montes de Oca Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco I","family":"Perez","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"issue":"19","key":"10.1002\/14651858.CD004349.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"suppl 2","key":"10.1002\/14651858.CD004349.pub2-BIB0002|cit2","first-page":"B54","article-title":"Effect of blood pressure control on diabetic complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","article-title":"Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes","volume":"61","author":"Schrier","year":"2002","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1002\/14651858.CD004349.pub2-BIB0009|cit4","first-page":"S9","article-title":"The Hypertension Optimal Treatment study and the importance of lowering blood pressure","volume":"17","author":"Hansson","year":"1999","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0004|cit5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/08037059409102281","article-title":"The Hypertension Optimal Treatment (HOT) Study. Patient characteristics: randomization, risk profiles, and early blood pressure results","volume":"3","author":"Hansson","year":"1994","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08037059509077613","article-title":"The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability with special reference to age and gender","volume":"4","author":"Hansson","year":"1995","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0007|cit8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08037059709062088","article-title":"The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability","volume":"6","author":"Hansson","year":"1997","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/08037059309077529","article-title":"The Hypertension Optimal Treatment Study (The HOT Study)","volume":"2","author":"Hansson","year":"1993","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00004872-200304000-00024","article-title":"Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?","volume":"21","author":"Zanchetti","year":"2003","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200106000-00021","article-title":"Effects of individual factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study","volume":"19","author":"Zanchetti","year":"2001","journal-title":"J Hypertens"},{"issue":"13","key":"10.1002\/14651858.CD004349.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.","volume":"330","author":"Klahr","year":"1994","journal-title":"N Eng J Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.HYP.29.2.641","article-title":"Achievement and safety of a low blood pressure goal in chronic renal disease","volume":"29","author":"Lazarus","year":"1997","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood Pressure Control, Proteinuria, and the Progression of Renal Disease: The Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised, controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1995.361","article-title":"\"Strict\" blood pressure control and progression of renal disease in hypertensive nephrosclerosis","volume":"48","author":"Toto","year":"1995","journal-title":"Kidney Int"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/08037059409102265","article-title":"The BBB Study Group: the effect of intensified antihypertensive treatment on the level of blood presure, side-effects, morbidity and mortality in \"well treated\" hypertensive patients","volume":"3","author":"Hansson L for the BBB Study Group","year":"1994","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00004872-198809000-00002","article-title":"The BBB study: a prospective randomized study of intensified antiihypertensive treatment","volume":"6","author":"The BBB Study Group","year":"1988","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s001250050614","article-title":"Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control","volume":"39","author":"Hypertension in Diabetes Study Group","year":"1996","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-6386(99)70036-3","article-title":"Effect on intensive blood pressure control on the course of type 1 diabetic nephropathy","volume":"34","author":"Lewis","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/jama.299.14.1678","article-title":"Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes","volume":"299","author":"Howard","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Goede","year":"2003","journal-title":"N Eng J Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"44i","DOI":"10.1016\/j.amjcard.2007.03.005","article-title":"Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99(12A)","author":"Cushman","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"The Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","article-title":"Standards of medical care in diabetes - 2008","volume":"31(Suppl 1)","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","article-title":"Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/diacare.25.1.134","article-title":"The treatment of hypertension in adult patients with diabetes","volume":"25","author":"Arauz-Pacheco","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0030|cit30","first-page":"423","article-title":"Isolated systolic hypertension in the elderly","volume":"24","author":"Aung","year":"2003","journal-title":"Cardiovasc Rev Rep"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0735-1097(99)00586-0","article-title":"A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men","volume":"35","author":"Benetos","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.328.7440.634","article-title":"British Hypertension Society Guidelines for hypertension management 2004 (BHS-IV): summary","volume":"328","author":"Williams","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-123-11-199512010-00010","article-title":"Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction","volume":"123","author":"Borzak","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0035|cit35","first-page":"151","article-title":"1999 World Health Organization - International Society of Hypertension Guidelines for the management of hypertension","volume":"17","author":"Chalmers J et al. WHO-ISH Hypertension Guidelines Committee","year":"1999","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.297.6658.1227","article-title":"Coronary flow reserve and the J-curve relation between diastolic blood pressure and myocardial infarction","volume":"297","author":"Cruickshank","year":"1988","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1007856014581","article-title":"Antihypertensive treatment and the J-curve","volume":"14","author":"Cruickshank","year":"2000","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents: A cautionary tale","volume":"119","author":"Dormuth","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertension"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0040|cit40","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23(suppl 2)","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.1991.03460040065031","article-title":"The J-curve phenomenon and the treatment of hypertension","volume":"265","author":"Farnett","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","article-title":"Is pulse pressure more important than systolic blood pressure in predicting coronary heart disease events?","volume":"100","author":"Franklin","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00004872-200304000-00004","article-title":"Observational epidemiological studies: values and limitations","volume":"21","author":"Gueyffier","year":"2001","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08037059209077502","article-title":"Prospective randomized open blinded end-point (PROBE) study","volume":"1","author":"Hansson","year":"1992","journal-title":"Blood Press"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08037059709062088","article-title":"The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability","volume":"6","author":"Hansson","year":"1997","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1007804030510","article-title":"Antihypertensive treatment: does the J-curve exist?","volume":"14","author":"Hansson","year":"2000","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1011928609508","article-title":"How far should we lower blood pressure in the elderly","volume":"15","author":"Hansson","year":"2001","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.35.5.1021","article-title":"Importance of systolic blood pressure in older americans","volume":"35","author":"Izzo","year":"2000","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Detection","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0050|cit50","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43 (5 Suppl 1)","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1996.03530440051036","article-title":"Blood pressure as a cardiovascular risk factor: prevention and treatment","volume":"275","author":"Kannel","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.317.7167.1185","article-title":"The unpredictability paradox: review of empirical comparisons of randomized and non-randomized clinical trials","volume":"317","author":"Kunz","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.328.7440.593","article-title":"Guidelines from the British Hypertension Society. The lower the pressure the better","volume":"328","author":"Laurent","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.HYP.29.2.641","article-title":"Achievement and safety of a low blood pressure goal in chronic renal disease","volume":"29","author":"Lazarus","year":"1997","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00004872-200304000-00010","article-title":"Intensive blood pressure treatment: beneficial for all but the smoking hypertensives?","volume":"21","author":"Lund-Johansen","year":"2003","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke and CHD. Part 1. Prolonged differences in blood pressure: prospective observational studies collected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(00)04017-4","article-title":"Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies","volume":"357","author":"MacMahon","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0059|cit59","first-page":"625","article-title":"The 2001 Canadian recommendations for the management of hypertension: Part two - Therapy","volume":"18","author":"2001 Canadian recommendations for the management of hypertension (McAlister","year":"2002","journal-title":"Can J Cardiol"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004872-199917080-00004","article-title":"Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial","volume":"17","author":"Millar","year":"1999","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril or both in patients at high risk for vascular events","volume":"358","author":"ONTARGET Investigators","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Oparil","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0895-4356(94)00150-O","article-title":"Large-scale randomized evidence: large simple trials and overviews of trials","volume":"48","author":"Peto","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00045391-200309000-00009","article-title":"Diabetes mellitus and hypertension: a mandate for intense treatment according to new guidelines","volume":"10","author":"Prisant","year":"2003","journal-title":"Am J Ther"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-138-7-200304010-00017","article-title":"The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus","volume":"138","author":"Snow","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.1993.00410050036006","article-title":"BP, systolic and dyastolic and cardiovascular risk.","volume":"153","author":"Stamler","year":"1993","journal-title":"Arch Intern Med"},{"issue":"Suppl V","key":"10.1002\/14651858.CD004349.pub2-BIB0069|cit69","first-page":"V65","article-title":"The relative importance of selective risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years. 30 years of follow-up in the Framingham Study","volume":"75","author":"Stokes","year":"1987","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-138-7-200304010-00018","article-title":"Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care","volume":"138","author":"Vijan","year":"2003","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1002\/14651858.CD004349.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.HYP.34.6.1181","article-title":"J-Shaped Relation Between Blood Pressure and Stroke in Treated Hypertensives","volume":"34","author":"Voko","year":"December 1999","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/sim.4780101105","article-title":"A general parametric approach to the meta-analysis of randomized clinical trials","volume":"10","author":"Whitehead","year":"1991","journal-title":"Stat Med"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","article-title":"2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension","volume":"21","author":"World Health Organization","year":"2003","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0074|cit74","first-page":"25","article-title":"Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?","volume":"161","author":"Wright","year":"1999","journal-title":"CMAJ"},{"issue":"4","key":"10.1002\/14651858.CD004349.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00004872-200304000-00024","article-title":"Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?","volume":"21","author":"Zanchetti","year":"2003","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD004349.pub2-BIB0076|cit76","unstructured":"Arguedas JA Blood pressure targets in the treatment of patients with elevated blood pressure Master's Thesis, Department of Pharmacology & Therapeutics, University of British Columbia July 2004"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004349.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004349.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:33:48Z","timestamp":1628544828000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004349.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004349.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004349.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,8]]}}}